Home / Resources

Resources

CDMO red flags you can’t ignore: Regulatory shortfalls and misalignment

Part 3: Could Regulatory Misalignment Be Delaying Your Submission? A CDMO can have the best scientists, excellent facilities, and strong technical execution, yet still fall short when it comes to regulatory alignment. This disconnect between scientific performance and regulatory readiness is one of the most damaging red flags in drug development as it could delay […]

Interviews

12.06.25

Insights into drug discovery and development 2025

Here we interview our Director of Medicinal Chemistry, Anita Wegert, for her insights into drug discovery and development for 2025. This interview was conducted an interviewer from the Drug Discovery and Development Europe event and we were able to share our expertise. Curious how our insights can help your next project?
Read more

Interviews

05.01.25

Interview with the computer-aided drug design (CADD) department

Our Computer Aided Drug Design department supports our clients' drug discovery projects with some of the best (predictive) software.
Read more

Interviews

16.12.24

Meet the Organix Director, Mario Gonzalez

We are pleased to share a conversation with Dr. Mario Gonzalez, a Director at Organix, as he reflects on his journey from Argentina to Massachusetts and provides valuable career insights in celebration of his 30 years with the company.
Read more

Interviews

01.11.23

Interview with the new Managing Director of Symeres Groningen

On October 2, Dr Melloney Dröge started in her new role as Managing Director for the Groningen site.
Read more

Interviews

18.01.23

An interview with Yadan Chen and Paul O’Shea

We are pleased to introduce the founders of Symeres’ daughter company Exemplify in New Jersey: Yadan Chen, CEO, and Paul O’Shea, Chief Scientific Officer. Who are they? What do they stand for? And how does Exemplify fit with Symeres?
Read more

Interviews

02.08.22

An interview with Anu Mahadevan and Paul Blundell

We proudly introduce the founders of Symeres’ daughter company Organix in Boston: Anu Mahadevan, CEO, and Paul Blundell, President at Organix. Who are they? What do they stand for? And how does Organix fit with Symeres?
Read more

Speak with our discovery and development experts

See how we can support the discovery and development of your next breakthrough.